These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 22172725

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation Study.
    Drechsler C, Pihlstrøm H, Meinitzer A, Pilz S, Tomaschitz A, Abedini S, Fellstrom B, Jardine AG, Wanner C, März W, Holdaas H.
    Transplantation; 2015 Jul; 99(7):1470-6. PubMed ID: 25675199
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study.
    Fellström B, Abedini S, Holdaas H, Jardine AG, Staffler B, Gimpelewicz C, Assessment of Lescol in Renal Transplantation (ALERT) study group.
    Clin Transplant; 2006 Jul; 20(6):732-9. PubMed ID: 17100723
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Osteoprotegerin and mortality in hemodialysis patients with cardiovascular disease.
    Winther S, Christensen JH, Flyvbjerg A, Schmidt EB, Jørgensen KA, Skou-Jørgensen H, Svensson M.
    Clin Nephrol; 2013 Sep; 80(3):161-7. PubMed ID: 23547804
    [Abstract] [Full Text] [Related]

  • 11. FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart.
    Ford ML, Smith ER, Tomlinson LA, Chatterjee PK, Rajkumar C, Holt SG.
    Nephrol Dial Transplant; 2012 Feb; 27(2):727-33. PubMed ID: 21750158
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation.
    Woo YM, McLean D, Kavanagh D, Ward L, Aitken S, Miller GJ, Egan P, Hughes K, Clark L, Carswell K, Morris ST, Northridge DB, Rodger RS, Jardine AG.
    J Nephrol; 2002 Feb; 15(4):380-6. PubMed ID: 12243367
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The role of myocardial scintigraphy in the assessment of cardiovascular risk in patients with end-stage chronic kidney disease on the waiting list for renal transplantation.
    Galvão De Lima JJ, Wolff Gowdak LH, de Paula FJ, Franchini Ramires JA, Bortolotto LA.
    Nephrol Dial Transplant; 2012 Jul; 27(7):2979-84. PubMed ID: 22302207
    [Abstract] [Full Text] [Related]

  • 17. Anemia is a predictor of graft loss but not cardiovascular events and all-cause mortality in renal transplant recipients: follow-up data from the ALERT study.
    Schjelderup P, Dahle DO, Holdaas H, Mjøen G, Nordby G, Abedini S, Jardine A, Fellström B, Svensson M.
    Clin Transplant; 2013 Jul; 27(6):E636-43. PubMed ID: 23991916
    [Abstract] [Full Text] [Related]

  • 18. Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism.
    Pihlstrøm H, Dahle DO, Mjøen G, Pilz S, März W, Abedini S, Holme I, Fellström B, Jardine AG, Holdaas H.
    Transplantation; 2015 Feb; 99(2):351-9. PubMed ID: 25594550
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
    Anand DV, Lahiri A, Lim E, Hopkins D, Corder R.
    J Am Coll Cardiol; 2006 May 02; 47(9):1850-7. PubMed ID: 16682312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.